Complete response of esophageal cancer achieved by combination therapy with 5-fluorouracil, low-dose cisplatin, and radiation: Report of a case

Surgery Today

Volumn 28, Issue 11, 1998, Pages 1163-1167

  Shimoyama, Shouji ^a,b   Konishi, Toshiro ^a   Kawahara, Masaki ^a   Hojo, Keiichi ^a   Takeda, Yuichi ^a   Nagayama, Takahisa ^a  

^a Showa General Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

5 fluorouracil; Chemoradiation; Cisplatin; Esophageal cancer; Radiosensitization

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; MALE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR REGRESSION;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031734137     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950050305     Document Type: Article

References (22)

1. Fink U, Stein HJ, Wilke H, Roder JD, Siewert JR (1995) Multimodal treatment for squamous cell esophageal cancer. World J Surg 19:198-204
2. Earlam R, Cunha-Melo JR (1980) Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 67:381-390
3. Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H (1990) Surgical therapy of oesophageal carcinoma. Br J Surg 77:845-857
4. Japanese Esophageal Oncology Group (1993) A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest 104:203-207
5. Schlag PM (1992) Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 127:1446-1450
6. Fok M, Sham JST, Choy D, Cheng SWK, Wong J (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113:138-147
7. Naunheim KS, Petruska PJ, Roy TS, Andrus CH, Johnson FE, Schlueter JM, Baue AE (1992) Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg 103:887-895
8. Ando N, Ozawa S, Miki H, Suwa T, Kitajima M (1995) Neoadjuvant chemotherapy and chemoradiotherapy in the treatment of esophageal cancer (in Japanese). Jpn J Cancer Chemother 22:1878-1885
9. Laterza E, Griso C, Urso US, De Manzoni G, Malago M, Oliani C, Cordiano C (1994) Induction therapy for squamous carcinoma of thoracic esophagus. Ann Thorac Surg 57:1126-1132
10. Apinop C, Puttisak P, Preecha N (1994) A prospective study of combined therapy in esophageal Cancer. Hepatogastroenterology 41:391-393
11. Yang L-X, Douple EB, O'Hara JA, Wang H-J (1995) Production of DNA double-strand breaks by interactions between carboplatin and radiation: a potential mechanism for radiopotentiation. Radiat Res 143:309-315
12. Sun J-R, Brown JM (1993) Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Radiat Res 133:252-256
13. Schaake-Koning C, Van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodrigus P, Schuster-Uitterhoeve L, Sculier J-P, Zandwijk N, Bartelink H (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524-530
14. Japanese Society for Esophageal Disease (1976) Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg 6:69-86
15. Beahrs OH, Henson DE, Hutter RVP. Myers MH (1988) Manual for staging of cancer. American Joint Committee on Cancer, 3rd edn. Lippincott, Philadelphia, pp 63-67
16. Miller AB, Hoogstraten B. Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207-214
17. Fisher B, Gunduz N, Saffer EA (1983) Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 43:1488-1492
18. Shirasaka T. Shimamoto Y, Ohshimo H, Saito H, Fukushima M (1993) Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 32:167-172
19. Skov K, MacPhail S (1991) Interaction of platinum drugs with clinically relevant X-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin. Int J Radiat Oncol Biol Phys 20:221-225
20. Kondo K, Murase M, Kodera Y, Akiyama S, Ito K, Yokoyama Y, Takagi H, Shirasaka T (1996) Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer. Oncology 53:64-67
21. Wolfe WG, Vaughn AL, Seigler HF, Hathorn JW, Leopold KA, Duhaylongsod FG (1993) Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 105:749-756
22. Forastiere AA, Orringer MB, Perez-Tamayo C. Urba SG. Zahurak M (1993) Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 11:1118-1123